CMOs are working hard to improve performance by investigating new technologies for filtration and purification. Downstream processing problems are not unique to CMOs, of course. It seems, however, ...

The author reviews the state of downstream processing and considers potential solutions, including the streamlining of full processes and borrowed technologies. The biopharmaceutical industry relies ...

Biomanufacturing is different from other processing industries. It is less able to sustain continuous end-to-end flows because it must contend with unique technical, practical, regulatory, and ...

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...